首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

酵素免疫分析法試驗 (ELISA) 市場規模、佔有率和成長分析（按產品類型、應用、技術、最終用戶和地區分類）—2026-2033 年產業預測

市場調查報告書

商品編碼

1913990

酵素免疫分析法試驗 (ELISA) 市場規模、佔有率和成長分析（按產品類型、應用、技術、最終用戶和地區分類）—2026-2033 年產業預測

Enzyme-Linked Immunosorbent Assay Market Size, Share, and Growth Analysis, By Product Type (Kits, Reagents), By Application (Clinical Diagnostics, Research), By Technology, By End User, By Region -Industry Forecast 2026-2033.

出版日期: 2025年12月30日 | 出版商:

SkyQuest | 英文 192 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球酵素免疫分析法(ELISA) 市場規模預計在 2024 年達到 25.2 億美元，從 2025 年的 26.5 億美元成長到 2033 年的 39.5 億美元，2026 年至 2033 年的複合年成長率為 5.1%。

全球酵素免疫分析法(ELISA) 市場正經歷強勁成長，這主要得益於慢性病和感染疾病的增加、檢測技術的進步以及在藥物研發和食品安全領域應用範圍的不斷擴大。 ELISA 以其對生物樣本中抗原和抗體的高精度定量分析而著稱，使其成為疾病監測領域中及時診斷和治療的關鍵工具。醫療保健模式從被動治療向預防性治療的轉變進一步提升了 ELISA 在疾病早期檢測方面的吸引力。此外，ELISA 在疫苗研發和品管中的關鍵作用也鞏固了其在製藥和研究領域的重要性。隨著人工智慧、機器學習、物聯網和區塊鏈等技術的融合，ELISA 市場也不斷發展，診斷效率和準確性也隨之提升。

全球酵素免疫分析法(ELISA) 市場按產品類型、應用、技術、最終用戶和地區進行細分。依產品類型分類，市場分為試劑盒、試劑和儀器。按應用分類，市場分為臨床診斷、科研、獸醫及其他。依技術分類，市場分為夾心 ELISA、間接 ELISA、競爭性 ELISA 和直接 ELISA。依最終用戶分類，市場分為醫院、診斷檢查室、研究實驗室及其他。按地區分類，市場分析涵蓋北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球酵素免疫分析法試驗 (ELISA) 市場促進因素

日益嚴峻的健康挑戰推動了對高效、擴充性且經濟實惠的診斷工具的需求，這顯著促進了酵素免疫分析法（ELISA）的應用。醫療機構、診斷檢查室和研究實驗室擴大將ELISA作為其標準診斷流程的重要組成部分，尤其是在需要高通量檢測的環境中。此方法能夠早期發現疾病進展，並實現對治療效果的持續監測和評估，這對於慢性病和非傳染性疾病的管理至關重要。因此，ELISA作為現代醫學的關鍵工具，其應用日益廣泛。

限制全球酵素免疫分析法（ELISA）市場的因素

全球酵素免疫分析法(ELISA) 市場面臨許多限制因素，主要體現在其對專有抗體、酵素偶聯物和專用試劑的依賴。這些產品需要高成本的生產流程、嚴格的檢驗和全面的品管措施。這些經濟負擔往往轉嫁給最終用戶，限制了資源匱乏地區用戶的使用。此外，多重 ELISA 檢測的複雜性也需要精細的最佳化來解決交叉反應、訊號干擾和試劑相容性等問題。這種複雜性為市場成長帶來了挑戰，尤其是在缺乏先進技術專長的地區，並總體上限制了 ELISA 技術的普及和應用。

全球酵素免疫分析法（ELISA）市場趨勢

自動化和高通量平台的應用是全球酵素免疫分析法(ELISA) 市場的一大顯著趨勢。實驗室和診斷中心正積極採用這些先進技術來提高營運效率。自動化 ELISA 分析儀能夠實現從上樣到結果報告的無縫流程，有效減少人為誤差並縮短結果獲取時間。這一趨勢在藥物研發等領域尤其明顯，因為在這些領域，快速篩檢大量樣本的能力至關重要。隨著對精準度和效率需求的不斷成長，預計在這些創新解決方案的推動下，市場將持續成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Merck KGaA
Danaher Corporation
Abcam plc
Becton, Dickinson and Company
Agilent Technologies, Inc.
R&D Systems, Inc.
Enzo Life Sciences, Inc.
Ortho Clinical Diagnostics
BioLegend, Inc.
RayBiotech, Inc.
QIAGEN NV
GenScript Biotech Corporation

結論與建議

簡介目錄

Product Code: SQMIG35A3109

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.65 Billion in 2025 to USD 3.95 Billion by 2033, growing at a CAGR of 5.1% during the forecast period 2026-2033.

The global enzyme-linked immunosorbent assay (ELISA) market is witnessing robust growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technology, and a broader range of applications in drug discovery and food safety. ELISA is renowned for its precision in quantifying antigens and antibodies in biological samples, making it a vital tool for timely diagnosis and treatment in the expanding realm of disease surveillance. The transition in healthcare from reactive to preventive approaches further enhances the appeal of ELISA for early disease detection. Moreover, its essential role in vaccine development and quality control solidifies its importance in pharmaceutical and research sectors. The market is also evolving with the integration of AI, machine learning, IoT, and blockchain technology, enhancing diagnostic efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

The rising prevalence of health challenges has led to a heightened demand for effective, scalable, and affordable diagnostic tools, significantly boosting the adoption of the Enzyme-Linked Immunosorbent Assay (ELISA). Healthcare facilities, diagnostic laboratories, and research institutions are turning to ELISA as an integral component of standard diagnostic processes, especially in scenarios that require high-throughput testing. This method facilitates early detection of disease progression and allows for ongoing monitoring and therapeutic evaluation, which are essential for managing both chronic and non-communicable diseases. Consequently, the reliance on ELISA continues to grow as a vital tool in modern healthcare.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market faces significant constraints due to the reliance on proprietary antibodies, enzyme conjugates, and specialized reagents, all of which demand costly production processes, stringent validation, and comprehensive quality control measures. Such financial burdens frequently transfer to end users, restricting access in resource-limited settings. Additionally, the intricacies involved in multiplexing ELISA tests necessitate meticulous optimization to manage issues like cross-reactivity, signal interference, and reagent compatibility. This complexity poses challenges for market growth, particularly in environments lacking advanced technical expertise, thereby limiting the overall reach and adoption of ELISA technologies.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is experiencing a notable trend toward the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating these advanced technologies to enhance operational efficiency. Automated ELISA analyzers facilitate seamless processes from plate loading to result reporting, effectively minimizing human error and accelerating turnaround times. This trend is particularly significant in sectors such as pharmaceutical research and vaccine development, where the capacity to rapidly screen large volumes of samples is critical. As the demand for precision and efficiency grows, the market is poised for sustained growth driven by these innovative solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2026-2033)

Market Overview
Kits
Reagents
Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Diagnostics
Research
Veterinary
Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2026-2033)

Market Overview
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Research Institutes
Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2026-2033)

North America (Product Type, Application, Technology, End User)
- US
- Canada
Europe (Product Type, Application, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R&D Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Life Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments